LFMD

LifeMD, Inc. LFMD

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,522 of 2,925

Why it scores 29Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$47.28M

Quarter to Jun 30

Net income

$-7.08M

Quarter to Jun 30

Free cash flow

$-6.99M

Quarter to Jun 30

Operating margin

-15.1%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$89.31M total
BlackRock, Inc.
$12.53M+8.0%
FEDERATED HERMES, INC.
$11.35M+169.6%
VANGUARD CAPITAL MANAGEMENT LLC
$7.16M+4.3%
STATE STREET CORP
$5.45M+22.6%
RENAISSANCE TECHNOLOGIES LLC
$4.46M-3.5%
GEODE CAPITAL MANAGEMENT, LLC
$4.41M+4.7%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
$3.71M+0.2%
BRC Group Holdings, Inc.
$2.63M-26.9%
ROYCE & ASSOCIATES LP
$2.63M-47.1%
AQR CAPITAL MANAGEMENT LLC
$2.56M+212.4%
MARSHALL WACE, LLP
$2.30M+116.8%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.98M+2.8%
MORGAN STANLEY
$1.67M+10.9%
MILLENNIUM MANAGEMENT LLC
$1.66MNew
NORTHERN TRUST CORP
$1.48M+6.7%
JACOBS LEVY EQUITY MANAGEMENT, INC
$1.39MNew
Walleye Capital LLC
$1.34MNew
Russell Investments Group, Ltd.
$1.30M+5801.2%
VANGUARD FIDUCIARY TRUST CO
$1.17M-1.7%
TUDOR INVESTMENT CORP ET AL
$1.13MNew
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.13M+17.4%
CITADEL ADVISORS LLC
$1.09MNew
BANK OF AMERICA CORP /DE/
$1.08M+435.9%
Bank of New York Mellon Corp
$1.02M+2.3%
Penn Capital Management Company, LLC
$926.1KNew
See all 117 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/LFMD

Earnings Per Share

13fpro.ai/company/LFMD

Loading ratio trend…

LFMD key financials by period

Reported revenue, net income and operating margin by fiscal year, from LifeMD, Inc.'s annual filings on SEC EDGAR.

LifeMD, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$194.1M$14.4M-4.0%
FY 2024$154.8M$-21.4M-13.2%
FY 2023$152.5M$-20.6M-9.5%
FY 2022$119.0M$-45.5M-36.5%
FY 2021$92.9M$-60.9M-58.5%
FY 2020$37.3M$-58.6M-155.0%
Source: LFMD filings on SEC EDGAR →

Companies similar to LFMD

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

LFMD insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About LifeMD, Inc. (LFMD): stock profile, AI score and financials

LifeMD, Inc. (LFMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LFMD at 28.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,522 of 2,925 stocks — the bottom half of the AI-ranked universe. LFMD scores in the top quartile across institutional flow (89.0). Areas of concern include earnings quality (1.0) and revenue growth (15.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), LifeMD, Inc. reports quarterly revenue of $47.3M, net income of $-7.1M, an operating margin of -15.1%. Top institutional holders of LFMD by reported 13-F value include BlackRock, FEDERATED HERMES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. LFMD trades on the Nasdaq exchange and files with the SEC under CIK 948320. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LFMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LifeMD, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 948320 →